Close
4

Seqens Seqens

X

Company profile for Cabaletta Bio

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Cabaletta Bio is a biopharmaceutical company focused on the discovery and development of T cell therapies for B cell-mediated autoimmune diseases. Cabaletta’s therapeutic platform produces highly selective autologous chimeric autoantibody receptor (CAAR) T cells that are designed to precisely ablate specific autoantibody-producing B cells while sparing normal antibody-producing B cells that protect the body from infection. C...
Cabaletta Bio is a biopharmaceutical company focused on the discovery and development of T cell therapies for B cell-mediated autoimmune diseases. Cabaletta’s therapeutic platform produces highly selective autologous chimeric autoantibody receptor (CAAR) T cells that are designed to precisely ablate specific autoantibody-producing B cells while sparing normal antibody-producing B cells that protect the body from infection. CAAR T cells are based on the revolutionary chimeric antigen receptor (CAR) T cell technology developed at the University of Pennsylvania that resulted in one of the first commercially-available CAR T cell therapies.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Cabaletta Bio
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
150 N Radnor Chester Rd Suite F-200 Radnor, PA 19087
Telephone
Telephone
+1 610 977 2422
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY